Welcome
Support Centre
02 October 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Early goal directed therapy following major surgery reduces complications and duration of hospital stay: a randomised, controlled trial
ISRCTN ISRCTN38797445
DOI 10.1186/ISRCTN38797445
ClinicalTrials.gov identifier
EudraCT number
Public title Early goal directed therapy following major surgery reduces complications and duration of hospital stay: a randomised, controlled trial
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis That post-operative goal directed therapy reduces the incidence of complications following major general surgery
Lay summary
Ethics approval Not provided at time of registration.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Major general surgery
Participants - inclusion criteria Patients aged 18 years or older presenting for major surgery expected to last more than one and a half hours were eligible for inclusion if one or more of the following criteria were satisfied before surgery:
1. Severe cardiac or respiratory illness resulting in severe functional limitation
2. Extensive surgery planned for carcinoma involving bowel anastamosis
3. Acute massive blood loss (greater than 2.5 l)
4. Aged over 70 years with moderate functional limitation of one or more organ systems
5. Septicaemia (positive blood cultures or septic focus)
6. Respiratory failure (partial pressure of oxygen in arterial blood [PaO2] less than 8 kPa on Fraction of inspired Oxygen [FiO2] greater than 0.4, i.e., PaO2 : FiO2 ratio less than 20 kPa or ventilation greater than 48 hours)
7. Acute abdominal catastrophe (e.g., pancreatitis, perforated viscous, gastro-intestinal bleed)
8. Acute renal failure (urea greater than or equal to 20 mmol/l, creatinine greater than 60 µmol/l)
9. Surgery for abdominal aortic aneurysm
Participants - exclusion criteria 1. Refusal of consent
2. Pregnancy
3. Acute myocardial ischaemia prior to enrolment
4. Patients receiving palliative treatment only
5. Disseminated malignancy
6. Patients unlikely to survive more than 6 hours
7. Patients requiring intervention outside intensive care unit (ICU) within the first 6 hours following surgery
8. Patients on lithium therapy
9. Weight less than 40 kg
Anticipated start date 01/11/2002
Anticipated end date 01/08/2004
Status of trial Completed
Patient information material
Target number of participants 300
Interventions Goal directed therapy protocol to achieve oxygen delivery index of 600 ml/min/m^2 compared to protocol designed to reflect standard care.
Primary outcome measure(s) Incidence of post-operative complications.
Secondary outcome measure(s) Mortality and duration of hospital stay.
Sources of funding The Intensive Care Research Fund managed by the St Georges Hospital charitable funds trustees (UK)
Trial website
Publications Results in http://www.ncbi.nlm.nih.gov/pubmed/16356219
Contact name Dr  Rupert  Pearse
  Address Intensive Care Unit
1st Floor St James' Wing
St George's Hospital
  City/town London
  Zip/Postcode SW170QT
  Country United Kingdom
  Tel +44 (0)7718 910 440
  Email rupert.pearse@doctors.net.uk
Sponsor St Georges Hospital (UK)
  Address Blackshaw Road
  City/town London
  Zip/Postcode SW17 0QT
  Country United Kingdom
Date applied 10/09/2005
Last edited 19/02/2008
Date ISRCTN assigned 28/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.